Monday 22 January 2018

Medical Billing Outsourcing Market Expected to Raise Till 2024 : Grand View Research, Inc.

The medical billing outsourcing market was valued at USD 6.3 billion in 2015 and is anticipated to reach a value of USD 16.9billion by 2024, according to a new report by Grand View Research, Inc. Large amount of medical code representation for diagnosis and treatment coupled with the presence of multiple payers renders medical billingan intricate part of any medical practice, posing significant challenges. The challenge mounts when this process mandates adherence to the International Classification of Diseases-10th revision (ICD-10) code along with dealing with rising healthcare costs and declining reimbursements. Challenges in managing in-house billing processes include setbacks experienced in the IT structure, untrained staff, billing errors, and lack of proper financial policy in place. In order to curb or alleviate these challenges, several healthcare providers,such as acute care hospitals and clinics/physician offices, prefer outsourcing their medical billing process. According to studies, in 2015, 95% of independent physicians have acknowledged that outsourcing revenue management is the right decision.
Healthcare providers face certain challenges in ascertaining the disadvantages of in-house operation or benefits of outsourcing revenue management operations;hence, they arrived at this decision by implementing thorough assessment and evaluation of the revenue percentage they spend on several billing operations. Currently, the healthcare system is witnessing a subsequent increase in outsourcing of medical billing services by hospitals and physicians. This increase is attributed to factors such as obligatory implementation of complex ICD-10 coding system, increasing healthcare costs, and federal mandate to implement electronic medical records (EMR) to maintain reimbursement levels.
Furthermore, clinics/physician offices are gradually outsourcing their revenue management to cut unnecessary costs and prevent the burden of managing an administrative team to ensure effectivehandling of in-house billing functions.
Further Key Findings From the Study Suggest:
·         North America reported highest revenue growth in this market. The U.S. is witnessing rapid changes in healthcare structure reflected by implementation of new medical coding system known as the ICD-10 coding as well as pressure from the government to implement EMR management system. These changing regulations coupled with rising healthcare costs are major growth drivers for the market in this region.
·         Multispecialty medical groups are implementing consolidation requiring electronic health record (EHR) integration and building large healthcare networks This integrationcreates a need forRevenue CycleManagement (RCM), which in turn demands additional expertise and trained personnel to manage the same. Consolidation of large healthcare practices is expected to be a one of the factors that will help in the growth of the market.
·         Hospitals end-use segment accounts for the largest market share in the medical billing outsourcing market. The ability to gain total control over billing procedures and minimize loss is the main focus of these providers. As healthcare costs rise and profits are decline, RCMoutsourcing is expected to be the best practice considered by these care facilities to manage their revenue.
·         Some of the key players in this industry include Accretive Health, Inc.; Allscripts; Cerner Corporation; EClinicalWorks; Experian Information Solutions, Inc.; GE Healthcare; Genpact; HCL; Kareo; McKesson Corporation; Quest Diagnostics; and The SSI Group.
Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/healthcare-it
Grand View Research has segmented the medical billing outsourcing market bycomponent, service and end user:
Component Outlook (Revenue, USD Million, 2013 - 2024)
·         In-House
·         Outsourced
Service Outlook (Revenue, USD Million, 2013 - 2024)
·         Front End
·         Middle End
·         Back End
End User Outlook (Revenue, USD Million, 2013 - 2024)
·         Hospitals
·         Physician Offices 
·         Others
Regional Outlook (Revenue, USD Million, 2013 - 2024)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    Japan
o    India
o    China
·         Latin America
o    Brazil
o    Mexico
·         MEA
o    South Africa
o    Saudi Arabia
View Press Release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-medical-billing-outsourcing-market

About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: 
www.grandviewresearch.com

Rehabilitation Equipment Market Expected To Grow Due To Increasing Prevalence Of Non-Communicable Diseases By 2025: Grand View Research, Inc.

The global rehabilitation devices/equipment market is expected to reach USD 17.5 billion by 2025, according to a new report by Grand View Research, Inc. Global increase in prevalence of degenerative diseases and number of trauma cases has led to a rise in number of patients in need of rehabilitation, which is anticipated to boost growth over the forecast period. 

Growing demand for rehabilitation devices in emerging economies is expected to boost the market in regions such as Asia Pacific and Latin America. Strengthened communication between manufacturers and customers due to various strategies employed by manufacturers, government awareness programs, subsidies, and reimbursement programs are few factors anticipated to promote growth.
Mobility equipment was the largest product category in 2016 and is expected to maintain its dominance during the forecast period. This segment held a share of nearly 37.1% in 2016. Exercise equipment segment is expected to witness the strongest growth over the forecast period owing to rise in number of physicians practicing physiotherapy and increase in adoption of physiotherapy in the rehabilitation process.
On the basis of end-use, the hospitals segment held a revenue share of nearly 33.1% in 2016 and is expected to be dominant during the forecast period. Large patient pool of hospitals and rapidly improving rehabilitation centers are amongst key factors attributing to the growth of this segment. Home care settings segment is expected to witness the fastest growth over the forecast period with a CAGR of around 7.4%. Economic benefits of home care over hospitals are primary causes of the anticipated growth. On the basis of geography, North America and Europe accounted for the largest share in 2015, whereas, the Asia Pacific market is expected to grow at a CAGR 8.2% between 2017 and 2025.

Further Key Findings From the Report Suggest:
·         The global rehabilitation devices market size was valued at USD 10.5 billion in 2016 and is expected to grow at a CAGR of 6.0% from 2017 to 2025
·         Mobility equipment was the largest product type segment in 2016 and is estimated to generate revenue over USD 6.7 billion by 2025
·         On the basis of end-use, the market size of hospital segment was valued at USD 3.5 billion in 2016 and is anticipated to witness high growth over the next nine years
·         The U.S. rehabilitation devices market size was valued at USD 2.9 billion in 2016 and is estimated to reach USD 4.4 billion by 2025
·         The rehabilitation equipment market in Asia Pacific is anticipated to witness substantial growth over the next decade owing to various developments taking place in major economies such as China, Japan, and India. The regional market is expected to grow at a CAGR of 8.2% from 2017 to 2025
·         Some players in rehabilitation devices market are Invacare Corporation; Medline Industries, Inc.; Dynatronics Corporation; Drive Devilbiss Healthcare; Esko Bionics; Caremax Rehabilitation Equipment Ltd.; GF Health Products, Inc.; Hospital Equipment Mfg. Co.; Maddak, Inc.; and India Medico Instruments
Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/medical-devices
Grand View Research has segmented the global rehabilitation devices/equipment market on the basis of product, application, end use and region: 
Product Outlook (Revenue, USD Million, 2014 - 2025)
·         Daily Living Aids
o    Medical Beds
o    Bathroom & Toilet Assist Devices
o    Reading Writing & Computer Aids
·         Mobility Equipment
o    Wheelchairs & Scooters
o    Walking Assist Devices
·         Exercise Equipment
o    Lower Body Exercise Equipment
o    Upper Body Exercise Equipment
·         Body Support Devices
o    Patient Lifts
o    Medical Lifting Slings
Application Outlook (Revenue, USD Million, 2014 - 2025)
·         Physiotherapy
·         Occupational Therapy
End Use Outlook (Revenue, USD Million, 2014 - 2025)
·         Hospitals & Clinics
·         Rehab Centers
·         Home Care Settings
·         Physiotherapy Centers
Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    U.K.
·         Asia Pacific
o    China
o    Japan
·         Latin America
o    Brazil
o    Mexico
·         Middle East & Africa
o    South Africa
View Press Release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-rehabilitation-devices-equipment-product-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: 
www.grandviewresearch.com




In-Flight Entertainment And Connectivity Market Size Projected To Grow Due To Surging Demand For Commercial Aviation & Fleet Expansion By 2024 : Grand View Research, Inc.

The global In-FlightEntertainment And Connectivity (IFEC) market size is expected to reach USD 9.82 billion by 2024, according to a new report by Grand View Research, Inc. The emergence of BYOD and development of novel wireless solutions are expected to boost market growth. The increasing commercial aviation & fleet expansion have further bolstered industry growth. Growing availability of HD content across dynamic platforms are expected to increase IFEC systems’ demand.
These systems can be categorized on the basis of product into hardware, connectivity, and content. Hardware is divided into portable and fixed while content is classified as streamed and stored. The portable hardware segment is expected to grow at a remarkable pace owing to the enhanced customer experience the devices offer.
Recent administrative regulations pertaining to the IFEC integration into aircraft in countries such as the U.S. are further expected to throttle industry growth. These regulations restrict the in-flight entertainment & connectivity integration to a certain degree to offer safe travel to passengers by minimizing the possibility of mishaps associated with the cabling and weight of these systems.
However, the IFEC system associated costs of content services and procurement costs are expected to pose challenges for the industry. The recent BYOD trend across industries, along with the advent of wireless portable electronic devices across dynamic sectors, is expected to impel the global IFEC market growth.
Further key findings from the report suggest:
·         Opportunities are presented by the market owing to the launch of innovations such as high throughput satellites in the Ka band and Ku band. This innovation is expected to increase the data speeds for connectivity and make the service provision cost efficient. With pressure rising in the airline sector as the major players are adopting cabin connectivity, other players need to adopt it to stay competitive.
·         The number of narrow body application planes in North America and Asia Pacific is multiplying with intense competition in the airlines industry, as a result of which the demand for these systems is to be significant in this segment. The U.S. and Canada are attractive markets on account of high flight connectivity and development in the technology followed by Europe.
·         The Asia Pacific in-flight entertainment and connectivity industry is expected to grow at a CAGR of close to 20% from 2016 to 2024. As the industry is dynamic, upgrades of the existing infrastructure incur high operational costs, installation time, and certification requirements. For embedded systems, it is thus necessary to ensure high returns on investment made in the infrastructure. The Bring Your Own Devices (BYOD) segment imposes logistical requirements and the need for updating & maintaining consistency across the fleet increases technological complexity.
·         Key industry participants include Cobham Plc., Global Eagle Entertainment Inc., Lufthansa Systems AG, Iridium Communications Inc., Thales Group S.A., OnAir, Viasat Inc., Gogo LLC, Panasonic Avionics Corporation, and Zodiac Aerospace S.A. The hardware suppliers are anticipated to dominate the content delivery industry to offer exclusive content, along with creating new revenue streams for airlines. In addition, they concentrate on evolving data storage competencies or collaborating with data centers to increase data volumes.
Browse more reports of this category by Grand View Research: https://www.grandviewresearch.com/industry/digital-media
Grand View Research has segmented the global In-Flight Entertainment And Connectivity (IFEC) market on the basis of product, aircraft type, and region:
In-Flight Entertainment & Connectivity Product Outlook (Revenue, USD Billion, 2014 - 2024)
·         Hardware
·         Connectivity
·         Content
In-Flight Entertainment & Connectivity Aircraft Type Outlook (Revenue, USD Billion, 2014 - 2024)
·         Narrow Body Aircraft (NBA)
·         Wide Body Aircraft (WBA)
·         Very Large Aircraft (VLA)
In-Flight Entertainment & Connectivity Regional Outlook (Revenue, USD Billion, 2014 - 2024)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    UK
·         Asia Pacific
o    China
o    Japan
·         Latin America
·         MEA
View Press Release of this research report by Grand View Research: https://www.grandviewresearch.com/press-release/global-ifec-market
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: 
www.grandviewresearch.com


Novel Drug Delivery Systems In Cancer Therapy Market To Set $26.6 Billion By 2025 : Grand View Research, Inc.

The global novel drug delivery systems (NDDS) in cancer therapy market is expected to reach USD 26.61 billion by 2025, according to a new report by Grand View Research, Inc. The market is primarily driven by global rise in incidence of cancer, increase in research activities for developing novel drug delivery technologies, and availability of research funding for ongoing projects. 
Many key players in this market are investing in R&D of novel and advanced products. This can also be attributed to increase in patent expirations. For instance, the R&D expenditure of Celgene Corporation increased from USD 3,697.3 million in 2015 to USD 4,470.1 million in 2016. Increase in R&D spending was directed toward enhancing product pipeline and for regulatory approvals of new products.
In addition, rise in healthcare expenditure for diagnosis and treatment of cancer and awareness about alternative therapies are expected to boost market growth. Improvement in healthcare infrastructure in developing nations and increase in awareness about new treatment methods for cancer are also anticipated to propel the market during the forecast period. 
North America held the largest market share in 2016. Local presence of a large number of manufacturers, ongoing regulatory approvals for new drugs, and availability of research funding for new methods of treatment for this disorder are key factors that can be attributed to this region’s dominance in the global market. However, Asia Pacific is expected to grow at the highest rate during the forecast period. This can be attributed to rise in initiatives that boost cancer research projects, increase in healthcare expenditure for cancer therapy, improvement in healthcare infrastructure, large geriatric population base, and rise in awareness owing to medical conferences and meetings in the region.

Further Key Findings From the Report Suggest:
·         The nanoparticles segment held the largest revenue share in 2016 due to increase in funding for research using these particles
·         The embolization particles segment is expected to grow at the highest rate during the forecast period owing to higher precision rate and accurate drug delivery
·         North America dominated the global market due to presence of a large number of cancer patients and favorable reimbursement scenario
·         Some of the key players are Celgene Corporation; Teva Pharmaceutical Industries, Ltd.; GALEN; Shire; Johnson & Johnson Services, Inc.; and Spectrum Pharmaceuticals, Inc.
Browse more reports of this category by Grand View Research:  https://www.grandviewresearch.com/industry/medical-devices
Grand View Research, Inc. has segmented the novel drug delivery systems (NDDS) in cancer therapy market on the basis of product and region:
 Product Outlook (Revenue, USD Million, 2014 - 2025)
·         Nanoparticles
o    Liposomes
o    Polymers
o    Micelles
o    Other nanoparticles
·         Embolization particles
o    PVA particles
o    Drug eluting beads
o    Liquid emboli
o    Other embolization particles
Regional Outlook (Revenue, USD Million, 2014 - 2025)
·         North America
o    U.S.
o    Canada
·         Europe
o    Germany
o    U.K.
·         Asia Pacific
o    China
o    Japan
·         Latin America
o    Brazil
o    Mexico
·         Middle East & Africa
o    South Africa
About Grand View Research
Grand View Research, Inc. is a U.S. based market research and consulting company, registered in the State of California and headquartered in San Francisco. The company provides syndicated research reports, customized research reports, and consulting services. To help clients make informed business decisions, we offer market intelligence studies ensuring relevant and fact-based research across a range of industries, from technology to chemicals, materials and healthcare.

For More Information: 
www.grandviewresearch.com